Importance Positron emission tomography (PET) combined with fludeoxyglucose F 18 (FDG)
is recommended for the noninvasive diagnosis of pulmonary nodules suspicious for lung …

PET and PET/CT have changed the diagnostic algorithm in oncology. Health care systems
worldwide have recently approved reimbursement for PET and PET/CT for staging of non …

Molecular imaging is rapidly gaining recognition as a tool with the capacity to improve every
facet of cancer care. Molecular imaging in oncology can be defined as in vivo …

Fluoro-deoxyglucose positron emission tomography (PET) imaging has a diagnostic and
prognostic value in the initial staging, restaging, and surveillance of non–small-cell lung …

Background Several techniques are currently available to improve the diagnostic yield of
routine flexible bronchoscopy. In the present study, we have evaluated the contribution of 2 …

Purpose To evaluate low dose non-enhanced CT and standard dose contrast-enhanced CT
in combined PET/CT protocols for staging and therapy planning of non-small cell lung …

Implementation of positron-emission tomography (PET) is variable depending on jurisdiction
in part due to uncertainty about cost-effectiveness. Our objective was to perform a systematic …

Fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET) and PET/computed
tomography (FDG-PET/CT) is regarded as a standard of care in the management of non …

The development and introduction of new diagnostic technologies have accelerated greatly
over the past few decades. This is reflected in a substantial expansion of research on …

BACKGROUND: The detection of micrometastases in thoracic lymph nodes may improve the
staging of non-small cell lung cancer patients. METHODS: Ten patients with resectable lung …